Join Jon and Pete Najarian on today's episode of Rebel's Edge as they discuss stocks including Novo Nordisk biggest loser day after Biden calls for cheaper Ozempic, Barry Diller's bid to take control of Paramount Global, Tesla spiking on higher-than-expected EV deliveries, and Ardelyx backing off from a new treatment use-case. Gain a deeper understanding of these stocks as Jon and Pete share their perspectives, potential growth prospects, and market predictions. They also talk about the Celtics payroll and the Atlanta Falcons prospects for the coming season. Stay on the cutting edge with Rebel's Edge.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.